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ABSTRACT
Objective: Nausea and vomiting during pregnancy (NVP) is very common, and may have great
impact on a woman’s life. The aim of this study was to explore thoughts and attitudes among
Norwegian pregnant women and GPs on treatment of NVP and pregnancy care. Design: Focus-
group study. Setting and subjects: Separate focus-group discussions were conducted with
pregnant women and GPs. Results: Two focus-group discussions were conducted with pregnant
women and two with GPs. The GPs thought it was important to normalize NVP symptoms.
However, the women felt their distress due to NVP was trivialized by the GPs. The women were
sceptical towards the use of medicines while pregnant, and avoidance was sought despite being ill.
The GPs appeared uncertain with respect to medical treatment of NVP, which was stated to be
considered only after progression to quite severe symptoms. Sick leave seemed to be an important
part of the treatment regime applied by the GPs. The women had good experiences with graded
sick leave. Conclusion: This Norwegian study identifies attitudes among GPs and pregnant women
that may act as obstacles to appropriate care for women with NVP. The pregnant women and the
GPs seemed to talk at cross-purposes; GPs’ normalization of the symptoms made the women feel
that their distress due to NVP was trivialized by the GPs. Our results indicate that pregnant women
with NVP requiring medical treatment probably need comprehensive and reassuring information
about treatment options before considering using any medicines.
KEY POINTS
Nausea and vomiting during pregnancy (NVP) is very common, and considered to be of clinical
significance for 35% of women.
 While the GPs agreed on the importance of normalizing the symptoms, the women felt their
distress was trivialized, and missed being properly evaluated.
 Both the GPs and the women showed a reluctant attitude to medical treatment of NVP.
 The GPs gave the impression of considering medical treatment only after progression of
symptoms to becoming quite severe.
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Nausea affects around 70% of pregnant women.[1]
Approximately 50% experience additional vomiting.[2,3]
Symptoms typically initiate during pregnancy weeks 6–8,
peaking around weeks 11–13, and subside within week
16.[2,3] The prevalence of hyperemesis gravidarum (HG),
the most severe form of nausea and vomiting during
pregnancy (NVP), is about 1%.[4] HG is characterized by
dehydration and electrolyte imbalance, and often leads
to hospitalization.[5]
Though some women privately celebrate the symp-
toms of nausea as one of the first signs of a longed-for
pregnancy,[6] prolonged nausea and vomiting during
pregnancy can be very debilitating for the women. For
about 35% of the women, NVP is clinically signifi-
cant.[2,5] NVP severely reduces the women’s quality of
life, and feelings of isolation and helplessness are
reported.[7–9] The ability to carry out daily activities is
impaired, including parenting, partly due to less inter-
action with their children.[9] Women report that NVP
adversely affects social functioning, relationship with
their partner, and also their partner’s daily life.[9,10]
Additionally, it leads to consumption of resources in the
health care system, and increased socio-economic costs
with increasing severity of NVP.[11,12] NVP is one of the
main reasons for being on sick leave during pregnancy,
reported to be responsible for almost one-third of total
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sick leave during pregnancy.[13] In Norway, as an
employee, you are entitled to sickness benefits if you
are occupationally disabled due to own illness or injury
and fulfil the demands to an employee as set by the
Norwegian Labour and Welfare Administration
(Norwegian short name: NAV).[14] Sick-leave certificates
can be issued by physicians. Sickness benefits equivalent
to full wages (up to a set amount) are received, paid by
the employer for the first 16 calendar days, and then by
NAV.[14] The sick leave may be full time or graded
(partial). The pregnancy care programme in Norway is
free of charge and pregnant women are entitled to nine
routine consultations with either their GP or a midwife,
and additional consultations if required.[15]
General practitioners (GPs) in the UK are alleged to be
reluctant to the use treatment against NVP.[16] Given
that NVP is one of the most commonly experienced
pregnancy complaints, and most often self-limiting,
women presenting with NVP may not always be taken
seriously. Canadian and American guidelines recom-
mend early treatment of the symptoms of NVP to reduce
costs related to hospitalizations, contacts with preg-
nancy care units, and sick leave, arguing that early
symptoms are easier to treat.[17,18] Given that NVP is
most commonly experienced during the first trimester,
and consequently during organogenesis, many women
and prescribers may be reluctant to use medications to
treat this complaint. This is reflected in a study from the
USA reporting that only 15% of women suffering from
NVP used any pharmacologic treatment.[19] Insufficient
safety data, preference for non-pharmacologic methods,
and being made to feel uncomfortable by the physician
are reported as common reasons for not using medi-
cines against NVP among Canadian women.[20] It is well
known that pregnant women often overestimate the risk
of medications during pregnancy.[21,22] Various
Norwegian treatment guidelines for NVP exist,[23–26]
but no medicines have NVP as an approved indication in
Norway, which further complicates the picture.
The aim of this study was to explore the thoughts and
attitudes among Norwegian pregnant women and GPs
on treatment of NVP and pregnancy care.
Design, material, and methods
A focus-group study was conducted with two groups of
pregnant women during November–December 2012
and two groups of GPs during December 2013.
Women attending routine ultrasound examination in
pregnancy week 17–18, and who had experienced NVP
in the current pregnancy, received an information
brochure together with an invitation to the study.
Snowball recruitment was also used as a strategy due
to a slow response among pregnant women at the
antenatal clinic. At the time of participation, all women
were still pregnant. In total, 10 women were recruited
and distributed in two focus groups of four and six
participants, respectively (Table 1). The discussions
lasted approximately 60 minutes. The women were
asked to tell about their own thoughts on and experi-
ences with pregnancy care and treatment of NVP.
To recruit GPs, educational groups for authorized and
practising GPs under specialization in general practice
were contacted via e-mail. Slow recruitment was also
experienced with regard to this source population. Two
focus-group discussions were conducted, each lasting 60
minutes, with five GPs in each group (see Table 1). The
GPs were asked to talk about their experience with and
thoughts on treatment of NVP.
All focus-group discussions were conducted accord-
ing to an interview guide to facilitate open discussion on
pre-identified themes.[27] Separate interview guides
were developed specifically for the pregnant women
and the GPs. However, divergences from the interview
guides occurred to facilitate a natural conversation in
the group. Three of the authors acted as group
moderators (HCS, IHS, LH), and one co-moderator in
each group took field notes. The focus-group discussions
were audio-recorded and transcribed verbatim. The
transcripts from the focus-group discussions with the
GPs and the pregnant women were analysed separately,
according to the principles of systematic text conden-
sation as described by Malterud.[28] First, the transcripts
were read as a whole by three of the authors to establish
an overview of data, followed by the identification of
preliminary themes representing different aspects of the
participants’ thoughts on and attitudes to treatment of
NVP. A collaborative negotiation strategy was applied.
Second, meaning units (a text fragment that contains
information regarding the research question) were
sorted under the appropriate themes or code groups.
Third, the content of the coded groups was reduced into
a condensate aiming to capture the essence of the
Table 1. Sample distribution of study participants.
Category Variables n
Pregnant women
Age Range 24–37 years
Education High school/vocational school 1
Bachelor degree/college 4
Master degree or higher 5
Parity No previous live birth 6




Age Range 27–48 years
Years of experience  5 years 8
45 years 2




































meaning units. Lastly, descriptions and concepts were
developed based on the condensates.
The study was approved by the Regional Committee




A call for acknowledgement. The women felt that their
NVP was trivialized by their GP. Even after it was
emphasized that NVP strongly impaired daily life func-
tioning and general well-being, the women were told
that symptoms of nausea are completely normal and
expected as part of being pregnant. The women felt
they were not taken seriously, and missed acceptance
and acknowledgement from their GP of how debilitating
NVP is to live with. The impact on social life and work
situation was mentioned. One woman also said it was
hard not being fully able to care for her other children
who were too young to understand why their mother
couldn’t play with them:
I told my GP that I was very bothered with nausea.
However, he just responded that nausea is very normal,
and that all pregnant women had it just like me. Nothing
to worry about. Even when I tried to emphasise the huge
impact the nausea had on my daily life, I just got the
impression that it was as expected. (W5)
Furthermore, they missed being evaluated properly for
the severity of their symptoms, and wanted to be asked
about their general well-being, weight, and diet. Close
follow-up was a request from many of the participants.
Inconsistent information resulted in scepticism and
insecurity. Information on treatment of NVP was sought
from numerous sources; GPs, pharmacies, internet,
family, and friends. Family, especially mothers, was a
good source of advice on folk remedies. However, the
women experienced a generational gap, themselves
being more sceptical to folk remedies than their mothers
or grandmothers. Though advice from pregnancy fora
on the internet was taken with a pinch of salt, it could be
used as an idea bank. Health care personnel were
considered the most trustworthy source of information,
and medical advice anchored in evidence-based medi-
cine was expected. However, the experience of many of
the participants was that information about treatment
was inconsistent between different health care person-
nel, which made the participants feel frustrated, scared,
and insecure:
You shouldn’t be given many different answers [from
various healthcare personnel]. You are sceptical and
insecure to begin with thinking that you are carrying
something in your belly that you may harm. If you ask
around for advice and get many different answers, this is
very frustrating and annoying. (W1)
Feelings of guilt. A healthy lifestyle, including a healthy
diet and regular exercise, was recognized by the partici-
pants as important during pregnancy. However, a strict
focus on this by health care personnel while the women
were suffering from NVP made the participants feel guilty
due to not being able to fulfil these expectations. When
they felt sick, they had to eat or drink whatever they
could handle, even if this meant less healthy types of
food and drinks, like crisps and soft drinks:
One might say that focus on a healthy diet is important,
but I think most pregnant women know what you
should or should not eat. In this condition it is all about
what I actually am able to eat. It would feel good to be
met by health care personnel that understand this. (W6)
One woman emphasized that she was worried about the
baby, and that it was reassuring to be told that the foetus’s
needs are fulfilled despite the mother not eating much:
My doctor told me that no matter how often you vomit,
the baby inside you takes what it needs, anyway. That is
good to hear, because when I came to the ultrasound
appointment in week seven or whatever, I had pictured a
starved little lemon inside me. (W2)
Medicines: Something for others, not for me. The
participants were generally very sceptical to the use of
medicines while pregnant. Avoidance was sought due to
fear of teratogenic effects with references to the
thalidomide tragedy during the 1960s. Some of the
participants also had the impression that GPs are
reluctant to treat NVP with medicines due to fear of
teratogenic effects, in contrast to their experience with
the specialist health service, which prescribed medicines
when needed. Though the participants themselves had
made the decision not to use medicines, they made it
clear that they realized that the choice of treatment of
NVP is individual. The question of treatment seemed to
depend on how much one can bear of the nausea’s
negative impact on social, occupational, and daily life
functioning, with the threshold set generally high:
I do not feel like medicating my discomfort, not when I
can actually manage to eat at least something. . .. But I
do not have anything against others who want to
medicate their nausea, or who are in need of medicines.
Because I cannot know other people’s needs, I only
know what is right for me. . .. I would never forgive
myself if something happened to the baby just because I
couldn’t stand the nausea. (W6)
In contrast to the reluctance to use medicines, one
woman, who had HG for the second time, thought that




































the GPs were too restrictive and that they delayed the
use of medicines too long:
Women lose a lot of weight and get dehydrated. I don’t
think it should be like that considering you are carrying a
child. I think it is important to have some quality of life
despite having NVP. (W8)
Graded sick leave: Something that is helpful. Most of
the participants had been on sick leave due to their NVP.
They had good experience of sick leave as helpful to
reduce stress, which was experienced as a trigger.
Managing to keep a part-time position, however, was
emphasized as positive, as this enabled some social
contact. To get off the couch and to think of other things
than NVP for a while could be helpful. Otherwise, as one
woman said, you will easily feel isolated, and a bit blue:
I think that, if one can manage, it would be best to be on
graded sick leave. To be able to get some social input.
And to get something out of the day, and get your
thoughts on to something other than nausea. Because
you get very easily focused on the nausea lying on the
couch the whole day. (W10)
The GPs
Emphasizing normality. The GPs pointed out that due to
NVP being one of many subjects on the list for the first
pregnancy consultation, there is limited time to ask
follow-up questions on how the pregnant women are
handling their NVP. A box is typically ticked if nausea is
confirmed, and unless the women have specific ques-
tions, the subject is left at that. If the women expressed
concern with regard to NVP, the participants highly
agreed on the importance of normalizing the condition
and assuring the woman that it is not harmful and not a
disease:
I think it is very important to normalize it. NVP is not a
disease, it is something to be expected while being
pregnant. (GP2)
The dilemma of prescribing sick leave: Appraised by the
women, criticized by NAV. Sick leave was presented as a
dilemma. A scenario with the Norwegian Labour and
Welfare Administration (NAV) on one side, demanding a
more restrictive policy for sick leave, and the women on
the other side, begging for sick leave was described.
They were also afraid that they might lose the patient if
they denied the woman going on sick leave:
According to NAV it’s all about the observations you
do. . .. But that’s the ‘‘NAV world’’, and we work in
another world. Our job is to build a relationship based
on trust. If we had to doubt all patients who come and
tell this kind of stories, it wouldn’t work out. (GP6)
Participants expressed a wish for an objective instru-
ment to measure symptoms of NVP as supportive
documentation of the reason for issuing sick leave.
The participants had a generally low threshold to
prescribe sick leave if the women were struggling with
NVP. It was spontaneously mentioned by the partici-
pants when they were discussing treatment of NVP in
general, giving the impression of sick leave being
viewed by the GPs as one of the first interventions
tried against NVP when action had to be taken, often
without concomitant prescription of medicines:
I don’t think I have experienced that a tablet is
what enables them to go to work. The result is sick
leave anyway. They have sometimes been given a
prescription in addition, to relieve the symptoms. (GP3)
Treatment with medicines is the next step: Or is it? When
the participants were asked about interventions against
NVP, they all agreed that advice on dietary and lifestyle
changes was a natural starting point, and something they
seemed to be confident of giving. However, in their
experience such measures were not of much help:
A woman with NVP had tried everything, and nothing
helped. She had biscuits on the night table, eating just
after waking up in the morning etc. It didn’t exactly
provide her with much relief. (GP8)
The GPs expressed reluctance to use medicines in the
treatment of NVP. However, if dietary and lifestyle
changes and/or sick leave were insufficient, the partici-
pants seemed to agree on medicines being the next
step. Medicines were only considered if the woman had
lost too much time from work, or was close to admission
to hospital due to NVP:
Treatment is something that is being considered if the
condition evolves to a great extent, but before the
women are admitted to hospital due to electrolyte
imbalance. When you feel you are in that phase where
admission to hospital needs to be prevented. (GP2)
Mmmhm. (GP3, GP4, GP5 nodding in agreement)
It was expressed that they did not feel comfortable
prescribing medicines against NVP due to awareness of
the teratogenic potential of use of medicines during the
first trimester, with references made to thalidomide.
Some of the GPs also agreed that they did not believe in
the effect of medicines against NVP:
You may try very carefully with medications with no
promise to the women that this is final quick fix. They
may as well not work. (GP5)
One GP even claimed that the cases which needed
pharmacological treatment should be referred to the




































hospital and, consequently, that pharmacological treat-
ment of NVP is outside the GP’s area of responsibility:
I do believe that when it has come so far that they are in
need of treatment because the NVP constitutes a health
risk, we refer them to the hospital. (GP10)
The participants missed a ‘‘go-to medicine’’, a medi-
cine that has NVP as one of the listed indications,
especially in the light of European Medicines Agency
(EMA)’s warning against metoclopramide.
Discussion
Principal findings
The participants, both the pregnant women and the GPs
in this study, elaborated on many issues related to
nausea and pregnancy care. The call for help due to
great distress seemed to be in conflict with the women’s
own scepticism regarding the use of medicines. The
women were concerned about potential harmful effects
of medicines when used during pregnancy, and there-
fore tried to avoid their use. They had rather negative
experiences of the meeting with health care profes-
sionals in relation to NVP, feeling that their distress due
to nausea was not taken seriously. On the other hand,
the GPs expressed that it was important to normalize
NVP. The GPs seemed unsure about how to treat NVP
when dietary and lifestyle interventions were insuffi-
cient. Though medicines were considered as the next
step, the overall attitude among the GPs was to avoid
medicines against NVP, mainly due to fear of teratogen-
icity. Below we discuss the strengths and limitations of
the study design and the impact of our findings.
Strengths and limitations
Although this study is not generalizable beyond the
participants in this setting, the data provide valuable
insight into thoughts and attitudes among GPs and
pregnant women that may be useful for GPs and other
health care personnel in contact with this patient group.
A focus-group design was chosen as this is considered
well suited to study attitudes and experiences among a
group of people within a specific milieu (e.g. health care
personnel or patients).[29] It is an efficient method to
gather data, and it also provides some quality control
through the participants’ own tendency to react to and
balance out extreme views.[30] The interaction taking
place within groups, which is considered to be the
hallmark of focus groups as a method,[31] was specif-
ically sought to help unveil concerns and priorities that
may explain behaviour patterns.[27] Due to slow recruit-
ment among pregnant women, a solely strategic
sampling was hindered, but the sample still turned out
to be quite diverse. Though the women were in general
highly educated, the age and parity varied among the
participants. The high level of education may act as a
limitation. However, the women without a high educa-
tion did not seem restrained and were well accepted in
the group, possibly because they had pregnancy and
nausea in common.
Our sample among GPs was relatively diverse, with
varying age and gender. However, eight GPs had less
than five years of experience. This may partly explain the
participating GPs’ uncertainty about the choice of
treatment after dietary and lifestyle advice was given.
Another possible limitation is that the groups of GPs
belonged to the same educational group, which may
result in withholding conflicting point of views.
However, the dynamic in the groups during the sessions
was good, and contradictory statements seemed to be
well tolerated. The groups were used to discussing
different topics during their normal educational sessions,
and the participants seemed comfortable with the
setting. Educational groups that do not have a positive
group dynamic would probably not accept an invitation
to participate in a focus-group study like this.
Due to slow recruitment, only two focus-group
discussions were conducted with each category of
participants. This is an exploratory study with the
intention to obtain new insight into the attitudes
behind the rationale of treatment of NVP among both
the receivers of the care and the caregivers, not to give a
full description that covers the complete picture, in
accordance with Malterud.[28] Based on the resulting
information-rich data and the broad spectrum of themes
that were uncovered, it was considered that two groups
were adequate. However, there is always the possibility
that conducting more group discussions might have
brought up relevant themes other than those covered
by this study.
Discussion of the findings
The pregnant women missed a deeper understanding of
and acknowledgement from health care personnel for
how debilitating nausea can be. The women’s call for
acknowledgement does not seem to be heard among
the GPs who rather strongly agreed on the importance
of normalization of the symptoms of NVP. The GPs had
good intentions by having this focus, as they thought it
was important to reassure the patient that nausea is not
harmful. However, it is our impression that the women
and the GPs talk at cross purposes. The focus on
normalization was interpreted by the women as if the
GPs did not take them seriously, especially when the GPs




































did not follow up with a proper clinical evaluation of the
women’s symptoms. Due to the high prevalence of
nausea and a busy schedule for the first pregnancy
consultation, the GPs admitted that nausea was often
just confirmed and not carefully assessed. A study of HG
patients from 2000 found that a high level of patient
satisfaction was associated with women’s perceptions
that physicians believed in their descriptions of their
symptoms.[32] Low level of belief in the patients may
result in delayed intervention, and consequently affect
the time for recovery,[32] illustrating the importance of a
good patient–GP relationship. This experienced lack of
understanding of NVP among health care personnel was
also described by Locock et al. in a study conducted in
2003–2004 illustrating minimal change in the situation
over the last decade.[6] The well-known fact that nausea
is very common during pregnancy and most often self-
limiting may partly explain why this complaint gets so
little attention. Also, national and international guide-
lines stress the importance of reassuring the women that
nausea is a normal part of pregnancy.[25,26,33]
However, there are several studies that describe NVP’s
negative impact on the women’s well-being resulting in
poor quality of life, symptoms of depression, and even
elective termination of an otherwise wanted preg-
nancy.[8–10,34] Locock et al. concluded that NVP was
as disruptive to everyday life as a chronic disease.[6]
Furthermore, 35% are considered to be clinically affected
by NVP and NVP accounts for 33% of all sick leaves
during pregnancy.[2,5,13] About 1% develop HG,[4]
which in most cases leads to hospitalization and its
related costs for the individual and the society.[5,12] HG
has also been associated with giving birth to low birth-
weight infants.[35] The participating GPs demonstrated a
low awareness of the negative impact of NVP.
While the women had a clear call for help, they gave a
rather mixed message with regard to what kind of help
they wanted. On one hand they criticized the GPs for not
offering any prescription of medicines, but on the other
hand they were clearly sceptical of taking medicines due
to being pregnant.
The women did not judge others for using medicines,
but tried to the utmost to avoid their use themselves. It
was a question of how much they could bear in order to
protect their child from the perceived harmful effects of
the medicines. This is in line with previous findings [20]
and is probably due to the previously described over-
estimation of risk of medicine use among pregnant
women.[22] Referral to the thalidomide tragedy was
made by the pregnant women as well as the GPs.
Though one GP stated that pharmacological manage-
ment of NVP was seen to be a specialist’s task, not a
GP’s, the other GPs agreed that pharmacological
treatment was the next step. However, they seemed
wary of treating NVP with medicines due to fear of
teratogenic effects. This is in line with publications from
UK,[16] but is a paradox as there is available evidence
supporting the safety of use during pregnancy of
antiemetics.[36] The GPs stated that medical treatment
of NVP was mainly considered after progression of
symptoms to becoming quite severe. The sceptical
attitude to medicines among the women in combination
with the normalization and lack of evaluation of symp-
toms, and the reluctant attitude to treatment among the
GPs, may prevent the question of treatment from being
raised during the patient–GP encounter. HG is likely to
be part of the continuum of nausea and vomiting during
pregnancy.[18] The literature indicates that failure of
early intervention against NVP increases risk for hospi-
talization due to HG,[37,38] illustrating the importance
of identifying those women in need of treatment at an
early stage. Hence, North American guidelines recom-
mend early intervention to prevent progression to HG
and more serious complications, including hospitaliza-
tion.[17,18] Our results indicate that pregnant women
requiring medical treatment against nausea would
probably need comprehensive information and reassur-
ance that there are treatment options that are con-
sidered to be effective and safe during pregnancy,
before they would consider taking medicines. But before
the participating GPs can take this position, they must
obtain the present evidence-based knowledge about
and confidence in available treatment options.
Improving quality of life during pregnancy and ability
to maintain day-to-day activities for women with NVP
should be reason enough for a GP to consider treatment.
GPs meet women early in their pregnancy and have the
opportunity to start symptom management at an early
stage. It is recommended to communicate positive
expectations regarding the outcome of a treatment to
apply the placebo effect as a supplement to the verified
treatment.[39] This contrasts the findings in this study
where some GPs expressed little confidence in the
treatment options they suggest to pregnant women.
The GPs missed clearer Norwegian treatment guide-
lines and called for a medicine with NVP as indication.
This may explain the women’s experiences of contra-
dictory information from different health care personnel,
and correction of prescriptions made by physicians other
than those issuing them, which were described by the
women who thought that this was scary and disturbing,
rendering them even more sceptical. These findings
indicate a lack of implementation of already existing
guidelines and a need for clearer and stepwise
guidelines that are easily accessible, to ensure consist-
ency between health care personnel involved with




































pregnancy care. Of note, Diclegis/Diclectin, a medi-
cine consisting of an antihistamine in combination with
pyridoxine, with NVP as approved indication, is available
in Canada and USA.
Most of the women had been on sick leave due to
NVP, and had good experiences related to graded sick
leave, which made the women feel less isolated as this
enabled social interaction with colleagues, and at the
same time having time to rest to relieve the symptoms.
Feelings of isolation have also previously been described
in relation to NVP.[7] During the discussions with the
GPs, sick leave was spontaneously mentioned when the
moderator primarily addressed treatment. There was an
impression that sick leave was an important part of the
treatment regime applied by the GPs, probably as a
consequence of a need for additional rest among
women with NVP and the reluctance to use medicines,
with sick leave being viewed as a safe intervention from
both sides. Sick leave often seems to be given without
the concomitant prescribing of medicines that could
give additional relief, or in some cases perhaps enable
the woman to work part time.
The question of prescribing sick leave was presented
as a dilemma. This demonstrates awareness among the
GPs who are trying to build an alliance with the women,
and at the same time acknowledging the criteria set by
NAV. This is in accordance with previous findings.[40] A
lack of an objective measure of nausea to enable
documentation for NAV on the grounds on which the
sick leave is being prescribed was mentioned in relation
to the sick leave dilemma. The Pregnancy-Unique
Quantification of Emesis (PUQE) scale has been trans-
lated into Norwegian and is included in the new national
guideline for treatment of NVP.[23,41] The PUQE scale
serves as a tool to help objectify the women’s NVP
symptoms, enables classification of degree of nausea
(mild, moderate, and severe) and is helpful in evaluating
the effect of various interventions.[41] However, the
experience of nausea, even if classified to the same
degree according to PUQE, may deviate between
different individuals. Hence, the women’s own experi-
ence should be acknowledged by the GPs and the
women treated accordingly.
Conclusion
This Norwegian study identifies attitudes among both
the participating GPs and pregnant women that may act
as obstacles to appropriate care of women suffering
from NVP. The GP’s automatic normalization of symp-
toms and lack of assessment of the burden of NVP is
interpreted as the main obstacle to appropriate care for
women suffering from this condition. Also the women’s
own scepticism regarding medical treatment while
pregnant may hinder appropriate treatment when
indicated. The pregnant women and the GPs talked at
cross-purposes: GPs’ normalization of the symptoms
made the women feel their distress due to NVP was
trivialized by the GPs. Our results indicate that pregnant
women requiring medical treatment against nausea
would probably need comprehensive information and
reassurance that there are safe treatment options for
NVP, before they would consider taking medicines.
However, the participating GPs showed reluctance
regarding the use of medicines to treat NVP, and
appeared to be insecure in terms of the safety and the
effectiveness of treatment.
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